Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

[ $^{18}F-FDG$ ] PET/CT in POEMS Syndrome

POEMS syndrome에서의 $^{18}F-FDG$ PET/CT 소견

  • An, Young-Sil (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine) ;
  • Yoon, Joon-Kee (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine) ;
  • Hong, Seon-Pyo (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine) ;
  • Joh, Chul-Woo (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine) ;
  • Yoon, Seok-Nam (Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine)
  • 안영실 (아주대학교 의과대학 핵의학교실) ;
  • 윤준기 (아주대학교 의과대학 핵의학교실) ;
  • 홍선표 (아주대학교 의과대학 핵의학교실) ;
  • 조철우 (아주대학교 의과대학 핵의학교실) ;
  • 윤석남 (아주대학교 의과대학 핵의학교실)
  • Published : 2007.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

POEMS syndrome is a rare disorder, also known as Crow-Fukase, PEP or Takatsuki syndrome. The acronym, POEMS, represents polyneuropathy, organomegaly, endocrinopathy, M protein and skin change. However, there are associated features not included in the acronym such as sclerotic bone lesions, Castleman disease, papilledema, thromobocytosis, peripheral edema, ascites, effusion, polycythemia, fatigue and clubbing. In most cases, osseous lesions in POEMS syndrome present as an isolated sclerotic deposit and that reveal as osteosclerotic myeloma. Several cases of $^{18}F-FDG$ PET in multiple myeloma involvements were reported, but there was no previous literature that reported FDG PET findings in POEMS syndrome. We describe here a 66-year-old patient with POEMS syndrome who underwent $^{18}F-FDG$ PET/CT image.

Keywords

References

  1. Chong ST, Beasley HS, Daffner RH. POEMS syndrome: radiographic appearance with MRI correlation. Skeletal radiology 2006; 35:690-5 https://doi.org/10.1007/s00256-005-0941-8
  2. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitiona and long-term outcome. Blood 2003;101:2496-506 https://doi.org/10.1182/blood-2002-07-2299
  3. Dispenzieri A. POEMS syndrome. Hematology(Am Soc Hematol Educ Program) 2005;360-7
  4. Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med 1994;97:543-53 https://doi.org/10.1016/0002-9343(94)90350-6
  5. Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, et al. The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 1984;34:712-20 https://doi.org/10.1212/WNL.34.6.712
  6. Mulleman D, Gaxatte C, Guillerm G, Leroy X, Cotten A, Duquesnoy B, Flipo RM. Multiple myeloma presenting with widespread osteosclerotic lesions. Joint Bone Spine 2004;71:79-83 https://doi.org/10.1016/S1297-319X(03)00152-0
  7. Schey S. Osteosclerotic myeloma and 'POEMS' syndrome. Blood Rev 1996;10:75-80 https://doi.org/10.1016/S0268-960X(96)90035-1
  8. Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR 2005;184:1199-204 https://doi.org/10.2214/ajr.184.4.01841199